Q2 PAT up 38%; H1 PAT up 156%, expansion on track

Multi-year targets disclosedInvestor Communications View source PDF Explain this filing

APCOTEXIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹485.50

prior close

₹494.05

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-0.4% vs market

Rubber peers, median of 10sector+0.1%-0.2% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.2 pts less than its Rubber peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.8

10m

-1.2

15m

-1.4

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1+0.3-0.4+0.1-0.2

Next day

+0.1+2.4-2.4+1.4-1.3

+1.1+3.6-2.5+4.2-3.1

-0.1pendingpending+1.9-2.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Rubber peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY27 revenue rose 48% to Rs 499 crore, EBITDA rose 44% to Rs 58 crore and PAT rose 38% to Rs 35 crore. EBITDA margin eased to 11.69% from 12.06% on inventory losses and high input costs. H1 EBITDA rose 121% to Rs 175 crore and PAT rose 156% to Rs 114 crore. It remained net cash positive. About Rs 65 crore of Rs 220 crore expansion spending is complete, and management expects 10% to 12% annual volume growth over three to five years.

Likely market impact

Strong profit growth and net cash support the outlook, but softer margins, elevated working capital and expansion spending may weigh on sentiment.